Literature DB >> 8687339

An ultrasonographic study of Peyronie's disease.

S Muralidhar1, M Gulati, B Kumar, S K Sharma, K Suman, P B Roy.   

Abstract

A study was undertaken to determine the usefulness of ultrasonography as an investigative tool, and its role in deciding the management of Peyronie's disease. Fifteen patients with Peyronie's disease were studied by ultrasonography. The plaque could be demonstrated in all patients. The dimensions of the plaque varied from less than 1 cm to more than 7 cm in length and 2-4mm in thickness. The disease was active in 26% of the patients, as indicated by the presence of hypoechoic areas around a central region of hyperechoism. Ultrasonogram was more accurate than clinical assessment in delineating the extent of lesions. In one-third of the patients, sonography demonstrated the plaques to be more extensive than had been detected by clinical examination. Calcification and activity of disease (which are clearly defined by ultrasonogram) are determining factors in the management of Peyronie's disease. This information allows the surgeon to select the modality of treatment, the timing of surgery and extent of excision. Thus, ultrasonography plays a vital role in the preliminary investigation and management of Peyronie's disease.

Entities:  

Mesh:

Year:  1996        PMID: 8687339     DOI: 10.1111/j.1440-1673.1996.tb00361.x

Source DB:  PubMed          Journal:  Australas Radiol        ISSN: 0004-8461


  2 in total

1.  Are sonographic characteristics associated with progression to surgery in men with Peyronie's disease?

Authors:  Benjamin N Breyer; Alan W Shindel; Yun-Ching Huang; Michael L Eisenberg; Dana A Weiss; Tom F Lue; James F Smith
Journal:  J Urol       Date:  2010-02-20       Impact factor: 7.450

2.  Ultrasound on Erect Penis Improves Plaque Identification in Patients With Peyronie's Disease.

Authors:  Yu Liu; Dequan Zheng; Xiaolin Liu; Xiaohong Shi; Shengchun Shu; Jinbing Li
Journal:  Front Pharmacol       Date:  2019-04-04       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.